Skip to main content

Advertisement

Log in

Antineoplastic drugs contamination of workplace surfaces in two Portuguese hospitals

  • Published:
Environmental Monitoring and Assessment Aims and scope Submit manuscript

Abstract

Despite the classification as known or suspected human carcinogens, by the International Agency for Research on Cancer, the antineoplastic drugs are extensively used in cancer treatment due to their specificity and efficacy. As human carcinogens, these drugs represent a serious threat to the healthcare workers involved in their preparation and administration. This work aims to contribute to better characterize the occupational exposure of healthcare professionals to antineoplastic drugs, by assessing workplace surfaces contamination of pharmacy and administration units of two Portuguese hospitals. Surface contamination was assessed by the determination of cyclophosphamide, 5-fluorouracil, and paclitaxel. These three drugs were used as surrogate markers for surfaces contamination by cytotoxic drugs. Wipe samples were taken and analyzed by HPLC-DAD. From the total of 327 analyzed samples, in 121 (37 %) was possible to detect and quantify at least one drug. Additionally, 28 samples (8.6 %) indicate contamination by more than one antineoplastic drug, mainly in the administration unit, in both hospitals. Considering the findings in both hospitals, specific measures should be taken, particularly those related with the promotion of good practices and safety procedures and also routine monitoring of surfaces contamination in order to guarantee the appliance of safety measures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Acampora, A., Castiglia, L., Miraglia, N., Pieri, M., Soave, C., Liotti, F., et al. (2005). A case study: surface contamination of cyclophosphamide due to working practices and cleaning procedures in two Italian hospitals. Annals of Occupational Hygiene, 49(7), 611–618.

    Article  CAS  Google Scholar 

  • Brouwers, E. E. M., Huitema, A. D. R., Bakker, E. N., Douma, J. W., Schimmel, K. J. M., van Weringh, G., et al. (2007). Monitoring of platinum surface contamination in seven Dutch hospital pharmacies using inductively coupled plasma mass spectrometry. International Archives of Occupational and Environmental Health, 80(8), 689–699.

    Article  CAS  Google Scholar 

  • Castiglia, L., Miraglia, N., Pieri, M., Simonelli, A., Basilicata, P., Genovese, G., et al. (2008). Evaluation of occupational exposure to antiblastic drugs in an Italian hospital oncological department. Journal of Occupational Health, 50, 48–56.

    Article  CAS  Google Scholar 

  • Cavallo, D., Ursini, C. L., Perniconi, B., Francesco, A. D., Giglio, M., Rubino, F. M., et al. (2005). Evaluation of genotoxic effects induced by exposure to antineoplastic drugs in lymphocytes and exfoliated buccal cells of oncology nurses and pharmacy employees. Mutation Research, 587(1–2), 45–51.

    Article  CAS  Google Scholar 

  • Connor, T. H., & McDiarmid, M. A. (2006). Preventing occupational exposures to antineoplastic drugs in health care settings. CA: A Cancer Journal for Clinicians, 56(6), 354–365.

    Google Scholar 

  • Connor, T. H., Sessink, P. J., Harrison, B. R., Pretty, J. R., Peters, B. G., Alfaro, R. M., et al. (2005). Surface contamination of chemotherapy drug vials and evaluation of new vial-cleaning techniques: results of three studies. American Journal of Health-System Pharmacy, 62(5), 475–484.

    CAS  Google Scholar 

  • Connor, T. H., DeBord, G., Pretty, J. R., Oliver, M. S., Roth, T. S. H., Lees, P. S., et al. (2010). Evaluation of antineoplastic drug exposure of health care workers at three university-based US cancer centers. JOEM, 52, 1019–1027.

    Google Scholar 

  • Davis, J., McLauchlan, R., & Connor, T. H. (2011). Exposure to hazardous drugs in healthcare: an issue that will not go away. Journal of Oncology Pharmacy Practice, 17(1), 9–13.

    Article  Google Scholar 

  • Delporte, J. P., Chenoix, P., & Hubert, P. H. (1999). Chemical contamination of the primary packaging of 5-fluorouracil RTU solutions commercially available on the Belgian market. European Journal of Hospital Pharmacy, 5, 119–121.

    Google Scholar 

  • Favier, B., Gilles, L., Ardiet, C., & Latour, J. F. (2003). External contamination of vials containing cytotoxic agents supplied by pharmaceutical manufacturers. Journal of Oncology Pharmacy Practice, 9, 15–20.

    Article  CAS  Google Scholar 

  • Fransman, W., Vermeulen, R., & Kromhout, H. (2004). Occupational dermal exposure to cyclophosphamide in Dutch hospitals: a pilot study. Annals of Occupational Hygiene, 48(3), 237–244.

    Article  CAS  Google Scholar 

  • Fransman, W., Vermeulen, R., & Kromhout, H. (2005). Dermal exposure to cyclophosphamide in hospitals during preparation, nursing and cleaning activities. International Archives of Occupational and Environmental Health, 78(5), 403–412.

    Article  CAS  Google Scholar 

  • Fransman, W., Peelen, S., Hilhorst, S., Roeleveld, N., Heederik, D., & Kromhout, H. (2007). A pooled analysis to study trends in exposure to antineoplastic drugs among nurses. Annals of Occupational Hygiene, 51(3), 231–239.

    Article  CAS  Google Scholar 

  • Fucic, A., Jazbec, A., Mijic, A., Seso-Simic, D., & Tomek, R. (1998). Cytogenetic consequences after occupational exposure to antineoplastic drugs. Mutation Research, 416(1–2), 59–66.

    Article  CAS  Google Scholar 

  • Hedmer, M., Jönsson, B. A. G., & Nygren, O. (2004). Development and validation of methods for environmental monitoring of cyclophosphamide in workplaces. Journal of Environmental Monitoring, 6, 979–984.

    Article  CAS  Google Scholar 

  • Hedmer, M., Georgiadi, A., Bremberg, E. R., Jönsson, B. A. G., & Eksborg, S. (2005). Surface contamination of cyclophosphamide packaging and surface contamination with antineoplastic drugs in a hospital pharmacy in Sweden. Annals of Occupational Hygiene, 49(7), 629–637a.

    Article  CAS  Google Scholar 

  • Hedmer, M., Tinnerberg, H., Axmon, A., & Jönsson, B. A. (2008). Environmental and biological monitoring of antineoplastic drugs in four workplaces in a Swedish hospital. International Archives of Occupational and Environmental Health, 81(7), 899–911.

    Article  CAS  Google Scholar 

  • Hirst, M., Tse, S., Mills, D. G., Levin, L., & White, D. F. (1984). Occupational exposure to cyclophosphamide. 1(8370), 186–188.

  • Hon, C. Y., Teschke, K., Chua, P., Venners, S., & Nakashima, L. (2011). Occupational exposure to antineoplastic drugs: identification of job categories potentially exposed throughout the hospital medication system. Safety and Health at Work, 2(3), 273–281.

    Article  CAS  Google Scholar 

  • Hon, C. Y., Teschke, K., Chu, W., Demers, P., & Venners, S. (2013). Antineoplastic drug contamination of surfaces throughout the hospital medication system in Canadian hospitals. Journal of Occupational and Environmental Hygiene, 10(7), 374–383.

    Article  CAS  Google Scholar 

  • Huang, Y. W., Jian, L., Zhang, M. B., Zhou, Q., Yan, X. F., Hua, X. D., et al. (2012). An investigation of oxidative DNA damage in pharmacy technicians exposed to antineoplastic drugs in two Chinese hospitals using the urinary 8-OHdG assay. Biomedical and Environmental Sciences, 25(1), 109–116.

    CAS  Google Scholar 

  • International Agency for Research on Cancer (IARC). (2012). Monographs on the evaluation of carcinogenic risks to humans. Some antiviral and antineoplastic drugs, and other pharmaceutical agents. Lyon, France: IARC Available from http://monographs.iarc.fr. Accessed 25 Oct 2013.

  • International Society of Oncology Pharmacy Practitioners ISOPP. (2007). ISOPP standards of practice: safe handling of cytotoxics. Journal of Oncology Pharmacy Practice, 13(Suppl), 1–81.

    Google Scholar 

  • Kiffmeyer, T. K., Tuerk, J., Hahn, M., Stuetzer, H., Hadtstein, C., Heinemann, A., et al. (2013). Application and assessment of a regular environmental monitoring of the antineoplastic drug contamination level in pharmacies—the MEWIP Project. Annals of Occupational Hygiene, 57(4), 444–455.

    Article  CAS  Google Scholar 

  • Kopjar, N., Garaj-Vrhovac, V., Kasuba, V., Rozgaj, R., Ramić, S., Pavlica, V., et al. (2009). Assessment of genotoxic risks in Croatian health care workers occupationally exposed to cytotoxic drugs: a multi-biomarker approach. International Journal of Hygiene and Environmental Health, 212(4), 414–431.

    Article  CAS  Google Scholar 

  • Kopp, B., Schierl, R., & Nowak, D. (2013). Evaluation of working practices and surface contamination with antineoplastic drugs in outpatient oncology health care settings. International Archives of Occupational and Environmental Health, 86(1), 47–55.

    Article  CAS  Google Scholar 

  • Kromhout, H., Hoek, F., Uitterhoeve, R., Huijbers, R., Overmars, R. F., Anzion, R., et al. (2000). Postulating a dermal pathway for exposure to anti-neoplastic drugs among hospital workers. Applying a conceptual model to the results of three workplace surveys. Annals of Occupational Hygiene, 44(7), 551–560.

    CAS  Google Scholar 

  • Larson, R. R., Khazaeli, M. B., & Dillon, H. K. (2002). Monitoring method for surface contamination caused by selected antineoplastic agents. American Journal of Health-System Pharmacy, 59(3), 270–277.

    CAS  Google Scholar 

  • Larson, R. R., Khazaeli, M. B., & Dillon, H. K. (2003). A new monitoring method using solid sorbent media for evaluation of airborne cyclophosphamide and other antineoplastic agents. Applied Occupational and Environmental Hygiene, 18(2), 120–131.

    Article  CAS  Google Scholar 

  • Mason, H. J., Morton, J., Garfitt, S. J., Iqbal, S., & Jones, K. (2003). Cytotoxic drug contamination on the outside of vials delivered to a hospital pharmacy. Annals of Occupational Hygiene, 47(8), 681–685.

    Article  CAS  Google Scholar 

  • Mason, H. J., Blair, S., Sams, C., Jones, K., Garfitt, S. J., Cuschieri, M. J., et al. (2005). Exposure to antineoplastic drugs in two UK hospital pharmacy units. Annals of Occupational Hygiene, 49(7), 603–610.

    Article  CAS  Google Scholar 

  • McDevitt, J. J., Lees, P. S., & McDiarmid, M. A. (1993). Exposure of hospital pharmacists and nurses to antineoplastic agents. Journal of Occupational Medicine, 35(1), 57–60.

    CAS  Google Scholar 

  • Minoia, C., Turci, R., Sottani, C., Schiavi, A., Perbellini, L., Angeleri, S., et al. (1998). Application of high performance liquid chromatography/tandem mass spectrometry in the environmental and biological monitoring of health care personnel occupationally exposed to cyclophosphamide and ifosfamide. Rapid Communications in Mass Spectrometry, 12(20), 1485–1493.

    Article  CAS  Google Scholar 

  • Miyake, T., Iwamoto, T., Tanimura, M., & Okuda, M. (2013). Impact of closed-system drug transfer device on exposure of environment and healthcare provider to cyclophosphamide in Japanese hospital. SpringerPlus; 2: 273. Available from http://www.springerplus.com/content/2/1/273. Accessed 25 Oct 2010.

  • Nygren, O., Gustavsson, B., Ström, L., & Friberg, A. (2002). Cisplatin contamination observed on the outside of drug vials. Annals of Occupational Hygiene, 46(6), 555–557.

    Article  CAS  Google Scholar 

  • Schierl, R., Böhlandt, A., & Nowak, D. (2009). Guidance values for surface monitoring of antineoplastic drugs in German pharmacies. Annals of Occupational Hygiene, 53(7), 703–711.

    Article  CAS  Google Scholar 

  • Schmaus, G., Schierl, R., & Funck, S. (2002). Monitoring surface contamination by antineoplastic drugs using gas chromatography-mass spectrometry and voltammetry. American Journal of Health-System Pharmacy, 59(10), 956–961.

    CAS  Google Scholar 

  • Sessink, P. J., Boer, K. A., Scheefhals, A. P., Anzion, R. B., & Bos, R. P. (1992). Occupational exposure to antineoplastic agents at several departments in a hospital. Environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers. International Archives of Occupational and Environmental Health, 64(2), 105–112.

    Article  CAS  Google Scholar 

  • Sessink, P. J., Van de Kerkhof, M. C., Anzion, R. B., Noordhoek, J., & Bos, R. P. (1994). Environmental contamination and assessment of exposure to anti-neoplastic agents by determination of cyclophosphamide in urine of exposed pharmacy technicians: is skin absorption an important exposure route? Archives of Environmental Health, 49(3), 165–169.

    Article  CAS  Google Scholar 

  • Shirato, S. (1992). Problems of cytotoxicity drug mainly based on antineoplastic tumor medicine. Japanese Journal of Medical Waste Research, 5, 1–32.

    Google Scholar 

  • Sugiura, S., Asano, M., Kinoshita, K., Tanimura, M., & Nabeshima, T. (2011). Risks to health professionals from hazardous drugs in Japan: a pilot study of environmental and biological monitoring of occupational exposure to cyclophosphamide. Journal of Oncology Pharmacy Practice, 17(1), 14–19.

    Article  CAS  Google Scholar 

  • Touzin, K., Bussières, J. F., Langlois, E., & Lefebvre, M. (2009). Evaluation of surface contamination in a hospital hematology–oncology pharmacy. Journal of Oncology Pharmacy Practice, 15, 53–61.

    Article  Google Scholar 

  • Touzin, K., Bussières, J. F., Langlois, E., Lefebvre, M., & Métra, A. (2010). Pilot study comparing the efficacy of two cleaning techniques in reducing environmental contamination with cyclophosphamide. Annals of Occupational Hygiene, 54(3), 351–359.

    Article  CAS  Google Scholar 

  • Turci, R., Sottani, C., Spagnoli, G., & Minoia, C. (2003). Biological and environmental monitoring of hospital personnel exposed to antineoplastic agents: a review of analytical methods. Journal of Chromatography, B: Analytical Technologies in the Biomedical and Life Sciences, 789(2), 169–209.

    Article  CAS  Google Scholar 

  • Turci, R., Minoia, C., Sottani, C., Coghi, R., Severi, P., Castriotta, C., et al. (2011). Occupational exposure to antineoplastic drugs in seven Italian hospitals: the effect of quality assurance and adherence to guidelines. Journal of Oncology Pharmacy Practice, 17(4), 320–332. doi:10.1177/1078155210381931

  • Yang, T., Cui, F., Choi, M., Lin, H., Chung, S., Shim, C., & Kim, D. (2007). Liposome formulation of paclitaxel with enhanced solubility and stability. Drug Delivery, 14(5), 301–308.

    Article  Google Scholar 

  • Yoshida, J., Koda, S., Nishida, S., Nakano, H., Tei, G., & Kumagai, S. (2013). Association between occupational exposure and control measures for antineoplastic drugs in a pharmacy of a hospital. Annals of Occupational Hygiene, 57(2), 251–260.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The study would not have been possible to develop without the financial support given by Portuguese Authority of Working Conditions (Project reference: 036APJ/09).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Susana Viegas.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Viegas, S., Pádua, M., Veiga, A.C. et al. Antineoplastic drugs contamination of workplace surfaces in two Portuguese hospitals. Environ Monit Assess 186, 7807–7818 (2014). https://doi.org/10.1007/s10661-014-3969-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10661-014-3969-1

Keywords

Navigation